Anebulo Pharmaceuticals Inc (ANEB)
2.05
+0.09
(+4.59%)
USD |
NASDAQ |
Sep 27, 16:00
2.105
+0.06
(+2.68%)
After-Hours: 20:00
Anebulo Pharmaceuticals Accounts Payable (Quarterly): 0.1564M for June 30, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 0.1564M |
March 31, 2024 | 0.3849M |
December 31, 2023 | 0.3187M |
September 30, 2023 | 0.5659M |
June 30, 2023 | 0.5345M |
March 31, 2023 | 0.5709M |
December 31, 2022 | 0.3466M |
September 30, 2022 | 0.5235M |
Date | Value |
---|---|
June 30, 2022 | 0.3808M |
March 31, 2022 | 0.0833M |
December 31, 2021 | 0.0429M |
September 30, 2021 | 0.4938M |
June 30, 2021 | 0.11M |
March 31, 2021 | 0.082M |
December 31, 2020 | 0.0845M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.0429M
Minimum
Dec 2021
0.5709M
Maximum
Mar 2023
0.3119M
Average
0.3466M
Median
Dec 2022
Accounts Payable (Quarterly) Benchmarks
Lifecore Biomedical Inc | 16.33M |
Ligand Pharmaceuticals Inc | 1.793M |
Revance Therapeutics Inc | 4.985M |
NovaBay Pharmaceuticals Inc | 1.235M |
Palatin Technologies Inc | 3.443M |